daltex 50+1000 mg filmovertrukne tabletter
medochemie ltd. - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+1000 mg
daltex 50+850 mg filmovertrukne tabletter
medochemie ltd. - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+850 mg
vedfa 50+850 mg filmovertrukne tabletter
pharmathen s.a. - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+850 mg
ipinzan 50+850 mg filmovertrukne tabletter
zentiva k.s. - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+850 mg
vilmenio 50+850 mg filmovertrukne tabletter
axunio pharma gmbh - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+850 mg
veldamet 50+850 mg filmovertrukne tabletter
maddox pharma swiss b.v. - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+850 mg
galvus
novartis europharm limited - vildagliptin - diabetes mellitus, type 2 - narkotika anvendt i diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
jalra
novartis europharm limited - vildagliptin - diabetes mellitus, type 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).
xiliarx
novartis europharm limited - vildagliptin - diabetes mellitus, type 2 - narkotika anvendt i diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).
vedfa 50+1000 mg filmovertrukne tabletter
pharmathen s.a. - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+1000 mg